Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 2, 1999, Pages 90-98

  Calistri, Arianna ^a   Parolin, Cristina ^a   Pizzato, Massimo ^a   Calvi, Paola ^a   Giaretta, Ilaria ^a   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CD4; CXCR4; Deoxyribonucleotide pools; HIV 1; HSV 1; Pseudotyping; Superinfection

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; CELL INTERACTION; CELL STIMULATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE; VIRUS ENVELOPE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DEOXYRIBONUCLEOTIDES; FLOW CYTOMETRY; GENOME, VIRAL; GIANT CELLS; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; LYMPHOCYTES; MITOGENS; NEUTRALIZATION TESTS; RECEPTORS, CXCR4; SUPERINFECTION; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS LATENCY;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033152315     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Nelson JA, Ghazal P, Wiley CA. Role of opportunistic infections in AIDS. AIDS 1990; 4:1-10.
2. Griffiths PD. Herpesviruses and AIDS. J Antimicrob Chemother 1996;37(Suppl B):87-95.
3. Griffiths PD. Studies of viral cofactors for human immunodeficiency virus in vitro and in vivo. J Gen Virol 1998;79:213-20.
4. Mosca JD, Bednarik DP, Raj NBK, et al. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds a trans-acting factor encoded by HSV-1. Nature 1987;325:67-70.
5. Ostrove MJ, Leonard J, Week EK, Rabson BA, Gendlman EH. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol 1987;61:3726-32.
6. Golden M, Kim S, Hammer MS, et al. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992; 166:494-9.
7. Vlach J, Pitha P. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1. J Virol 1993;67:4427-31.
8. Vlach J, Pitha P. Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kB enhancer and leader sequence. J Virol 1992;66:3616-23.
9. Cooper DA, Perllson O, Pederson C. The efficacy and safety of zivudine alone or cotherapy with acyclovir in the treatment of patients with AIDS and AIDS related complex: double blind randomized trial. AIDS 1988;7:197-207.
10. Youle HS, Gattrd BG, Johonson MA. Effects of high dose oral ACV on herpesvirus disease and survival patients with advanced HIV diseases: a double blind, placebo controlled study. AIDS 1994;8:641-9.
11. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996;23:429-40.
12. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected persons. JAMA 1998;280:61-66.
13. Heng CYM, Heng SY, Allen GS. Coinfection and synergy of human immunodeficiency virus-1 and herpes simplex virus 1. Lancet 1994;343:255-8.
14. Zhu Z, Chen SSL, Huang AS. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr 1990;3:215-9.
15. Braun WR, Teute HK, Kirchner H, Munk K. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. J Immunol 1984;132:914-9.
16. Braun WR, Kirchner HT. T lymphocytes activated by interleukin 2 alone acquire permissiveness for replication of herpes simplex virus. Eur J Immunol 1986;6:706-11.
17. Hammer SM, Carney WP, Iacoviello VR, Lowe BR, Hirsh MS. Herpes virus infection of human T-cell subpopulations. Infect Immun 1982;38:795-9.
18. Hammer SM, Richter SB, Hirsch M. Activation and suppression of herpes simplex virus in a human T lymphoid cell line. J Immunol 1981;127:144-8.
19. Plaeger-Marshall S, Smith WJ. Infection of subpopulation of human peripheral blood leukocytes by herpes simplex virus. J Infect Dis 1978;138:506-11.
20. Rinaldo C. Jr, Richter SB, Black O, Callery R, Chess L, Hirsch SM. Replication of herpes simplex and cytomegalovirus in human leukocytes. J Immunol 1978;120:130-6.
21. Soslau G, Pastorino MA, Morgan D, Brodsky IK, Howett M. Herpes simplex virus replication and protein synthesis in a human blood-derived cell line. J Gen Virol 1987;68:2079-92.
22. Palù G, Gerna G, Bevilacqua F, Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res 1992; 23:133-44.
23. Parolin C, Taddeo B, Palù G, Sodrosky J. Use of cis- and transacting viral regulatory sequences to improve expression of HIV-1 vectors in human lymphocytes. Virology 1996;222:415-22.
24. Marcello A, Loregian A, Cross A, Marsden H, Hirst T, Palù G. Specific inhibition of HSV replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc Natl Acad Sci USA 1994;19:8994-8.
25. Sherman PA, Fyfe AJ. Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primer. Anal Biochem 1989;180:222-6.
26. Lachmann RH, Efstathiou S. Utilisation of the herpes simplex virus type 1 latency associated region to drive stable reporter gene expression in the nervous system. J Virol 1997,71:3197-207.
27. Fauci A. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
28. Feng, Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry co-factors: functional cDNA cloning seven transmembrane, G-protein coupled receptor. Science 1996;272:872-7.
29. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-41.
30. Clouse KA, Robbins PB, Fernei B, Ostrove JM, Fauci AS. Viral antigen stimulation of the production of human monokines capable of regulating HIV-1 expression. J Immunol 1989;143:470-5.
31. Lusso P, DeMaria A, Malnati M, Lori F, DeRocco SE, Bassen M. Induction of CD4 and susceptibility to HIV-1. Nature 1991;349: 533-5.
32. Michelson S, Dal Monte P, Zipeto D, et al. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol 1997;71:6495-6500.
33. Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1993;90:8925-8.
34. Lori F, Malykin A, Cara A, et al. Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication. Science 1994; 266:801-805.
35. Meyerhans A, Vartanian JP, Hultgren K, et al. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxyribonucleoside triphosphate pools. J Virol 1994;68:535-40.
36. Goldenberg D, Mador N, Ball JM, Pallet A, Steiner I. The abundant latency associated transcript of herpes simplex virus type 1 is bound to polyribosomes in cultured neuronal cells and during latent infection mouse trigeminal ganglia. J Virol 1997;71:2897-904.
37. Nicosia M, Zabbtny MJ, Lirette PR, Frasen N. The HSV-1 2 kb LAT is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology 1994;204:717-28.
38. Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Ann Rev Microbiol 1987;41:543-71.
39. Jamieson AT, Bjursell G. Deoxyribonucleoside triphosphate pools in herpes simplex type 1 infected cells. J Gen Virol 1976;31:101-13.
40. Aiken C. Pseudotyping of the human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to Cyclosporin A. J Virol 1997;71:3341-5.
41. Landau NR, Page KA, Littman DR. Pseudotyping with the human T-cell leukaemia virus type 1 broadens the human immunodeficiency virus host range. J Virol 1991;65:162-9.
42. Diaz JJ, Dodon MD, Schaerer-Uthurralt N, et al. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature 1996;18:273-7